Qualitative Analysis of the Design and Implementation of Benefit-Sharing Programs for Biologics Across Europe.
Teresa Barcina LacostaArnold G VultoAdina Turcu-StiolicaIsabelle HuysSteven R A SimoensPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2022)
To realize the full potential of benefit-sharing programs, we identify the importance of (i) setting up and timely monitoring success indicators for these programs; (ii) including quality of care and access to care parameters as success indicators; (iii) establishing clear pathways for the transparent redistribution/reinvestment of savings and (iv) transparently communicating with patients about the outcomes of benefit-sharing programs.
Keyphrases
- public health
- quality improvement
- healthcare
- health information
- social media
- palliative care
- end stage renal disease
- ejection fraction
- newly diagnosed
- primary care
- prognostic factors
- systematic review
- pain management
- affordable care act
- type diabetes
- adipose tissue
- metabolic syndrome
- risk assessment
- chronic pain
- skeletal muscle